摘要
通过联合检测卵巢癌患者及对照组的T淋巴细胞亚群和SOD水平，结果发现1．卵巢癌组SOD水平明显低于健康组（P＜0．05）；2．卵巢癌组OKT3及OKT8均值低于健康组，但无显著性差异，OKT4均值则有显著性下降（P＜0．05）；3．化疗后卵巢癌患者SOD稍有下降，T4／T8下降明显（P＜0．05）。提示联合检测SOD和T淋巴细胞亚群对卵巢癌的早期诊断、鉴别诊断，预后及化疗过程中免疫功能变化都具有一定的临床实用价值。
We have combined to determine the levels of superoxide dismutase and T lymphocyte subpopulations in patients with ovarian cancer with normal controls. The result showed that the levels of SOD in patientswith ovarian cancer was significanly lower than that of the normal control (p＜0.05); the percentage Of OKT3,OKT8 was lower but not remarkable; OKT4 was significantly lower (P＜0. 05 ); after chemotherapy. The OKT4/OKT8 ratio was significantly lower (P＜0.05). It indicated that combination in determination of t...
出处
《江苏医药》
CAS
CSCD
1994年第5期242-244,共3页
Jiangsu Medical Journal
关键词
卵巢癌
超氧化物歧化酶
T淋巴细胞亚群
双途径化疗
免疫功能
Ovarian cancer
Superoxide dismutase
T Lymphocyte subpopulations
Two-Route chemotherapy
Immune function
